Sequence improvements to pharmaceutical regulatory quality systems so that each step makes the next one easier.
Building Quality Management Systems in Pharmaceutical Regulation
A structured, applied course in pharmaceutical regulatory quality systems — designed to be used the week you return.
📍 Istanbul🗓️ 5 training days📚 4 modules🎓 Accredited certificate
5intensive training days
4scientific modules
8training sessions
32detailed points
Course Overview
Accreditation bodies assess pharmaceutical regulatory quality systems on documented evidence of consistent practice. The data supporting quality systems is usually present but rarely assembled into a decision. Content is organised around the decisions practitioners actually face in this area of health and pharmaceutical services, not around theory headings. Mature organisations treat pharmaceutical regulatory quality systems as a standing capability rather than a project that finishes. The difficulty is not agreeing that this strand of health and pharmaceutical services matters — it is deciding what to stop doing to make room for it. Participants come from operational and oversight roles, and both perspectives on quality systems are used deliberately. The course leaves participants able to diagnose weaknesses in pharmaceutical regulatory quality systems before they become incidents. Each session closes with a decision the participant must justify about quality systems in their own setting. Participants finish with a short, specific brief on this aspect of health and pharmaceutical services ready to put in front of a decision maker.
Expected Learning Outcomes
Plan continuity of quality systems during surge, outbreak and emergency.
Assign clear ownership for each element of pharmaceutical regulatory quality systems across the functions involved.
Set acceptance criteria for quality systems before work begins rather than after.
Design escalation for clinical deterioration detected through pharmaceutical regulatory quality systems.
Plan staffing and rota cover appropriate to demand in quality systems.
Build the quality indicators for pharmaceutical regulatory quality systems that reflect patient outcome, not activity.
Who Should Attend
Operations staff who encounter the consequences of pharmaceutical regulatory quality systems directly.
Analysts producing the data on which decisions about quality systems rest.
Nursing managers and clinical supervisors delivering pharmaceutical regulatory quality systems.
Regulatory affairs specialists handling quality systems.
Quality and patient safety officers monitoring pharmaceutical regulatory quality systems.
Finance managers costing services delivered through quality systems.
Course Modules
Pharmaceutical regulatory quality systems: cost, efficiency and sustainability of the service
2 sessions · 8 pointsSession 1Testing pharmaceutical regulatory quality systems before relying on it
- Plan continuity of pharmaceutical regulatory quality systems during surge and outbreak conditions.
- Build medication safety checks into quality systems at the point of highest risk.
- Confirm that contractual obligations around pharmaceutical regulatory quality systems are understood.
- Confirm that those complying with quality systems understand why it exists.
Session 2The decisions in quality systems that cannot be delegated
- Confirm licensing and regulatory requirements applying to pharmaceutical regulatory quality systems are met.
- Prepare the summary of quality systems that senior management will read.
- Check that consent processes within pharmaceutical regulatory quality systems are genuinely informed.
- Reduce unwarranted variation in quality systems between shifts and sites.
Quality systems: regulation, licensing and accreditation evidence
2 sessions · 8 pointsSession 1What has to be agreed before work on quality systems starts
- Review whether pharmaceutical regulatory quality systems is aligned with the objectives of the clinical service.
- Assign responsibility for keeping documentation of quality systems current.
- Anticipate the objections pharmaceutical regulatory quality systems will raise and prepare the answers.
- Prepare the response for the most likely failure in quality systems.
Session 2Making incident reporting on quality systems safe for staff
- Select quality indicators for pharmaceutical regulatory quality systems that measure outcome rather than activity.
- Test the procedure for quality systems against a realistic scenario.
- Set the review interval for pharmaceutical regulatory quality systems and who attends.
- Compare the cost of quality systems with the cost of its absence.
Quality systems: staffing, capacity and demand
2 sessions · 8 pointsSession 1The evidence assessors will ask for on quality systems
- Map the clinical workflow for pharmaceutical regulatory quality systems as it is actually performed.
- Verify six months later that changes to quality systems have held.
- Measure patient experience of pharmaceutical regulatory quality systems and feed it back to the team.
- Benchmark the organisation's quality systems against comparable operations.
Session 2Infection risk created by pharmaceutical regulatory quality systems
- Match staffing levels on pharmaceutical regulatory quality systems to measured demand across the week.
- Verify cold chain and storage conditions for materials used in quality systems.
- Identify infection transmission risks created by pharmaceutical regulatory quality systems and control them.
- Close the loop: confirm changes to quality systems improved the indicator they targeted.
Quality systems: incident reporting, investigation and learning
2 sessions · 8 pointsSession 1Auditing quality systems at the bedside, not in the binder
- Set escalation thresholds for pharmaceutical regulatory quality systems that work out of hours.
- Record what was learned when quality systems did not go as planned.
- Distinguish symptoms from causes when pharmaceutical regulatory quality systems underperforms.
- Agree what will be standardised in quality systems and what will not.
Session 2Matching staffing on quality systems to real demand
- Define escalation criteria for deterioration detected through pharmaceutical regulatory quality systems.
- Confirm the incident reporting route for quality systems is quick and non-punitive.
- Audit pharmaceutical regulatory quality systems by observing practice, not by reading policy.
- Cost quality systems per episode and identify avoidable waste.
Choose the package that suits you
Silver Package
At least 3 people
USD1,250
- Workshop or Program Participation
- Airport Transfers
- Customized Badge
- Expert Mentorship (Private Sessions)
- Supervision & Secretarial Services
- Accredited Certificate of Participation
- Complete Training Kit
- Coffee Break
- Closing Ceremony
Gold Package
At least 3 people
USD1,850
- 5-night stay in a 5-star hotel
- Workshop or Program Participation
- Airport Transfers
- Customized Badge
- Expert Mentorship (Private Sessions)
- Supervision & Secretarial Services
- Accredited Certificate of Participation
- Complete Training Kit
- Coffee Break
- Closing Ceremony
Complete your registration
We will contact you within one business day to confirm.